Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0003 Transporter Info | ||||
| Gene Name | ABCB1 | ||||
| Transporter Name | P-glycoprotein 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Trifluoperazine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 5566 | ||||
| Docking Score | -9.097 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C21H24F3N3S | ||||
| Molecular Weight | 407.5 | ||||
| Canonical SMILES |
CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F
|
||||
| InChI |
InChI=1S/C21H24F3N3S/c1-25-11-13-26(14-12-25)9-4-10-27-17-5-2-3-6-19(17)28-20-8-7-16(15-18(20)27)21(22,23)24/h2-3,5-8,15H,4,9-14H2,1H3
|
||||
| InChIKey | ZEWQUBUPAILYHI-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 5 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 7 | ||
| Xenobiotic Name | Naringenin Drug Info | ||||
| Xenobiotic Type | Drug in Phase 1 Trial | ||||
| MOA | Inhibition | ||||
| PubChem CID | 932 | ||||
| Docking Score | -9.078 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C15H12O5 | ||||
| Molecular Weight | 272.25 | ||||
| Canonical SMILES |
C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O
|
||||
| InChI |
InChI=1S/C15H12O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-6,13,16-18H,7H2
|
||||
| InChIKey | FTVWIRXFELQLPI-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.4 | Rotatable Bond Count | 1 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 5 | ||
| Xenobiotic Name | Desloratadine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 124087 | ||||
| Docking Score | -9.075 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C19H19ClN2 | ||||
| Molecular Weight | 310.8 | ||||
| Canonical SMILES |
C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
|
||||
| InChI |
InChI=1S/C19H19ClN2/c20-16-5-6-17-15(12-16)4-3-14-2-1-9-22-19(14)18(17)13-7-10-21-11-8-13/h1-2,5-6,9,12,21H,3-4,7-8,10-11H2
|
||||
| InChIKey | JAUOIFJMECXRGI-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 4.5 | Rotatable Bond Count | 0 | |
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.